March 4, 2022

Within3 on the MAPS Elevate podcast: Using technology to identify experts

Learn why medical affairs organizations are using data and network analytics to identify KOLs and DOLs to drive insights generation.
Medical affairs KOL identification

Not long ago, the right experts for medical affairs programs used to be those who published the most or were particularly prolific speakers at medical congresses and conferences. In other words, the loudest academic or scientific voices in the industry.

While that perception persists for some medical affairs teams and life science leadership, many have discovered that advancements in network analytics can open the door to experts across the globe – specifically, the experts doing the work most relevant to the stage and disease state of a product’s development and commercial pathway. At different points, medical affairs teams need different expertise to generate the most strategic insights. At times those may be treating physicians, but at other times these insights may come from researchers, referrers, and other niche experts.

Disconnected data sources and list-based approaches have traditionally hindered the discovery of these experts for medical affairs teams, leaving insight gaps. In the first episode of this tech-centered series on the MAPS Elevate podcast channel, learn how emerging technology is helping teams be more effective in their KOL identification efforts.

Listen as Within3 CEO Lance Hill and Vice President of Product Marketing Samantha Veeck talk with MAPS’ Garth Sundem about two critical innovations: widening data sets and the application of network analytics. Evidence suggests that medical affairs teams that don’t adopt these technologies may assign resources to incorrect experts 20 percent of the time – or one of every five meetings. Teams applying these tools can reduce that number to five percent, accounting for a significant competitive advantage.

Listen to the 20-minute episode or learn more about using virtual engagement to strengthen relationships with KOLs. You can also catch up with CEO Lance Hill on another episode of the MAPS Elevate Podcast about medical affairs insight generation.

Related Posts:

Within3 Announces Acquisition of rMark Bio™

Within3 announced today the acquisition of rMark Bio, allowing for deeper access to and more efficient delivery of KOL and stakeholder insights to life science companies worldwide.
virtual engagement technology

Within3 in BMC Ophthalmology

Virtual engagement technology increases the value of patient and HCP interaction.

Within3 CEO Lance Hill on Yahoo Finance

Lance Hill discusses Within3’s $100 million growth funding round on Yahoo Finance.